Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 31, 2023	Mar. 31, 2023
ASSETS
Cash and cash equivalents	$ 6,458	$ 6,398
Restricted cash and cash equivalents	1,992	2,090
Investments in marketable securities	4,873	5,037
Finance receivables, net of allowance for credit losses of $1,605 and $1,489, respectively	100,884	90,280
Investments in operating leases, net	28,571	29,869
Other assets	4,040	3,921
Total assets	146,818	137,595
LIABILITIES AND SHAREHOLDER'S EQUITY
Debt	119,006	111,685
Deferred income taxes	3,225	3,727
Other liabilities	6,760	5,674
Total liabilities	128,991	121,086
Commitments and contingencies (Refer to Note 9)
Shareholder's equity:
Capital stock, no par value (100,000 shares authorized; 91,500 issued and outstanding) at December 31, 2023 and March 31, 2023	915	915
Additional paid-in capital	2	2
Accumulated other comprehensive loss	(57)	(57)
Retained earnings	16,967	15,649
Total shareholder's equity	17,827	16,509
Total liabilities and shareholder's equity	$ 146,818	$ 137,595